<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Children and Adolescents</title>
<title_fa>مجله بین المللی کودکان و نوجوانان</title_fa>
<short_title>IJCA</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijca.iums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn></journal_id_issn>
<journal_id_issn_online>2645-6435</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2016</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>2</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Amiloride vs hydrochlorthiazide therapy in children with nephrotic syndrome: A clinical trial</title>
	<subject_fa>دیگر</subject_fa>
	<subject>Other</subject>
	<content_type_fa>پژوهشي اصیل</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background and Objective: To assess the effectiveness and safety of oral amiloride for the treatment of&lt;br&gt;
edema in pediatric patients with idiopathic nephrotic syndrome.&lt;br&gt;
Methods: A randomized trial of amiloride vs hydrochlorthiazide was done in 34 patients. The mean age was&lt;br&gt;
4.3&amp;plusmn;0.7 years old. After a 2 week washout of diuretic therapy, nephrotic children with edema were randomized&lt;br&gt;
into two groups receiving amiloride vs hydrochlorthiazide. The effect of diuretics was assessed by the amount of&lt;br&gt;
weight reduction and the measurement of urinary fractional excretion of sodium during the first three days of&lt;br&gt;
diuretic therapy. The primary end point was the decrease in body weight.&lt;br&gt;
Findings: Of 34 patients enrolled for this trial, 17 patients were in amiloride group and 17 patients in hydrochlorthiazide&lt;br&gt;
group. The mean weight loss during the first three days of diuretic therapy was 1.3&amp;plusmn;0.65 kg in&lt;br&gt;
amiloride group and 1.19&amp;plusmn;0.4 kg in hydrochlorthiazide group (PV=0.55). The mean of maximum urinary fractional&lt;br&gt;
excretion of sodium during the first three days of diuretic therapy was 2.1&amp;plusmn;0.65% in amiloride group and&lt;br&gt;
1.8&amp;plusmn;1% in hydrochlorthiazide group.&lt;br&gt;
Conclusion: There was not any difference between amiloride and hydrochlorthiazide medications in reducing&lt;br&gt;
weight and increasing urinary fractional excretion of sodium in children with nephrotic syndrome.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Amiloride, hydrochlorthiazide, Children, Nephrotic syndrome</keyword>
	<start_page>29</start_page>
	<end_page>31</end_page>
	<web_url>http://ijca.iums.ac.ir/browse.php?a_code=A-10-1-46&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Soheila </first_name>
	<middle_name></middle_name>
	<last_name>Mahdavinia</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600320</code>
	<orcid>1003194753284600320</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hasan</first_name>
	<middle_name></middle_name>
	<last_name> Otukesh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600321</code>
	<orcid>1003194753284600321</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Rozita </first_name>
	<middle_name></middle_name>
	<last_name>Hoseini</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rozitahoseini@yahoo.com</email>
	<code>1003194753284600322</code>
	<orcid>1003194753284600322</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mehrdad </first_name>
	<middle_name></middle_name>
	<last_name>Shheikhvatan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600323</code>
	<orcid>1003194753284600323</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
